Autor: "Gao, F." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Vaccine with bacterium-like particles displaying HIV-1 gp120 trimer elicits specific mucosal responses and neutralizing antibodies in rhesus macaques.
Autorzy:: Wang H; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.
Li P; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences, Guangzhou, 510530, China.
Zhang M; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.
Bi J; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.
He Y; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences, Guangzhou, 510530, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.
Li F; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.
Yu R; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.
Gao F; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.; Department of Medicine, Duke University Medical Center, Durham, NC, 27710, USA.
Kong W; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.; Key Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, China.
Yu B; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.
Chen L; State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences, Guangzhou, 510530, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510060, China.
Yu X; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.; Key Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, China.; Pokaż więcej
Źródło:: Microbial biotechnology [Microb Biotechnol] 2022 Jul; Vol. 15 (7), pp. 2022-2039. Date of Electronic Publication: 2022 Mar 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: AIDS Vaccines*
HIV-1*
Animals ; Antibodies, Neutralizing ; Guinea Pigs ; HIV Antibodies/analysis ; Immunoglobulin A, Secretory ; Immunoglobulin G ; Macaca mulatta ; Mice ; Mucous Membrane/chemistry

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers.
Autorzy:: Kumar A; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Giorgi EE; Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
Tu JJ; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Martinez DR; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Eudailey J; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Mengual M; Department of Medicine, Duke University Medical Centre, Durham, North Carolina, United States of America.
Honnayakanahalli Marichannegowda M; Department of Medicine, Duke University Medical Centre, Durham, North Carolina, United States of America.
Van Dyke R; Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Gao F; Department of Medicine, Duke University Medical Centre, Durham, North Carolina, United States of America.
Permar SR; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2021 Apr 02; Vol. 17 (4), pp. e1009478. Date of Electronic Publication: 2021 Apr 02 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Genetic Variation*
Infectious Disease Transmission, Vertical*
Broadly Neutralizing Antibodies/*immunology
HIV Antibodies/*immunology
HIV Infections/*virology
HIV-1/*genetics
env Gene Products, Human Immunodeficiency Virus/*genetics
Female ; HIV Infections/transmission ; HIV-1/immunology ; HIV-1/physiology ; Humans ; Infant ; Mothers ; Phylogeny ; Pregnancy ; env Gene Products, Human Immunodeficiency Virus/immunology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations.
Autorzy:: Ji H; National HIV and Retrovirology Laboratories at JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Parkin N; Data First Consulting Inc., Sebastopol, CA 95472, USA.
Gao F; Duke Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Denny T; Duke Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Jennings C; Department of Molecular Pathogens and Immunity, Rush University, Chicago, IL 60612, USA.
Sandstrom P; National HIV and Retrovirology Laboratories at JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Kantor R; Division of Infectious Diseases, Brown University Alpert Medical School, Providence, RI 02906, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2020 May 18; Vol. 12 (5). Date of Electronic Publication: 2020 May 18.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Quality Assurance, Health Care*/organization & administration
Drug Resistance, Viral/*genetics
HIV-1/*genetics
High-Throughput Nucleotide Sequencing/*standards
Sequence Analysis, RNA/*standards
Congresses as Topic ; Diagnostic Tests, Routine/standards ; Genotype ; HIV Infections/virology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.
Autorzy:: Lee ER; National HIV and Retrovirology Laboratories, National Microbiology Laboratory at JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
Gao F; Department of Medicine, Duke University Medical Center, Durham, NC, 27710, USA.
Sandstrom P; National HIV and Retrovirology Laboratories, National Microbiology Laboratory at JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, R3E 0J9, Canada.
Ji H; National HIV and Retrovirology Laboratories, National Microbiology Laboratory at JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, R3E 0J9, Canada.; Pokaż więcej
Źródło:: Viruses [Viruses] 2020 May 16; Vol. 12 (5). Date of Electronic Publication: 2020 May 16.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Drug Resistance, Viral/*genetics
HIV Infections/*virology
HIV-1/*genetics
High-Throughput Nucleotide Sequencing/*standards
Sequence Analysis, RNA/*standards
Anti-HIV Agents/pharmacology ; Anti-HIV Agents/therapeutic use ; Genotype ; HIV Infections/drug therapy ; HIV-1/drug effects ; Laboratory Proficiency Testing/standards ; Mutation ; Quality Assurance, Health Care

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Development of Antibodies with Broad Neutralization Specificities against HIV-1 after Long Term SHIV Infection in Macaques.
Autorzy:: Gao N; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
Gai Y; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
Meng L; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
Wang C; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
Zhang X; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
Wang W; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Beijing 100021, China.; Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Qin C; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Beijing 100021, China.; Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Yu X; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.; Key Laboratory for Molecular Enzymology and Engineering, the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.
Gao F; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.; Departments of Medicine, Duke University Medical Center, Durham, NC 27710, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2020 Jan 31; Vol. 12 (2). Date of Electronic Publication: 2020 Jan 31.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibodies, Neutralizing/*immunology
Antibodies, Viral/*blood
HIV Antibodies/*immunology
HIV-1/*immunology
Simian Immunodeficiency Virus/*immunology
Animals ; Antibodies, Neutralizing/biosynthesis ; Genes, env/genetics ; Genes, env/immunology ; HIV Antibodies/biosynthesis ; HIV Seropositivity ; Macaca mulatta/immunology ; Mutation ; Neutralization Tests ; Simian Acquired Immunodeficiency Syndrome/immunology ; Simian Immunodeficiency Virus/genetics ; Time Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.
Autorzy:: Kumar A; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Smith CEP; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Giorgi EE; Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
Eudailey J; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Martinez DR; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Yusim K; Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
Douglas AO; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Stamper L; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
McGuire E; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
LaBranche CC; Department of Surgery, Duke University Medical Centre, Durham, North Carolina, United States of America.
Montefiori DC; Department of Surgery, Duke University Medical Centre, Durham, North Carolina, United States of America.
Fouda GG; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Gao F; Department of Medicine, Duke University Medical Centre, Durham, North Carolina, United States of America.; National Engineering Laboratory for AIDS Vaccine, College of Life Science, Jilin University, Changchun, Jilin, China.
Permar SR; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2018 Apr 19; Vol. 14 (4), pp. e1006944. Date of Electronic Publication: 2018 Apr 19 (Print Publication: 2018).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Infectious Disease Transmission, Vertical*
Antibodies, Neutralizing/*immunology
HIV Infections/*transmission
HIV-1/*genetics
Plasma/*metabolism
Pregnancy Complications, Infectious/*etiology
env Gene Products, Human Immunodeficiency Virus/*immunology
Female ; Genetic Variation ; HIV Antibodies/immunology ; HIV Infections/immunology ; HIV Infections/virology ; Humans ; Infant ; Neutralization Tests ; Peripartum Period ; Pregnancy ; Pregnancy Complications, Infectious/metabolism ; env Gene Products, Human Immunodeficiency Virus/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies.
Autorzy:: Liu D; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin, China.; Department of Medicine, Duke Human Vaccine Institute, Duke University Medical Center, 303 Research Dr., 244 Sands Building, DUMC 102359, Durham, NC, 27710, USA.; Division II of In Vitro Diagnostics for Infectious Diseases, Institute for In Vitro Diagnostics Control, National Institutes for Food and Drug Control, Beijing, China.
Wang C; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin, China.; Department of Medicine, Duke Human Vaccine Institute, Duke University Medical Center, 303 Research Dr., 244 Sands Building, DUMC 102359, Durham, NC, 27710, USA.
Hora B; Department of Medicine, Duke Human Vaccine Institute, Duke University Medical Center, 303 Research Dr., 244 Sands Building, DUMC 102359, Durham, NC, 27710, USA.
Zuo T; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin, China.; Department of Medicine, Duke Human Vaccine Institute, Duke University Medical Center, 303 Research Dr., 244 Sands Building, DUMC 102359, Durham, NC, 27710, USA.
Goonetilleke N; Department of Microbiology, Immunology and Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Liu MKP; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, England, UK.
Berrong M; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Ferrari G; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
McMichael AJ; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, England, UK.
Bhattacharya T; Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM, USA.
Perelson AS; Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM, USA.
Gao F; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin, China. .; Department of Medicine, Duke Human Vaccine Institute, Duke University Medical Center, 303 Research Dr., 244 Sands Building, DUMC 102359, Durham, NC, 27710, USA. .; Pokaż więcej
Źródło:: Retrovirology [Retrovirology] 2017 Oct 10; Vol. 14 (1), pp. 46. Date of Electronic Publication: 2017 Oct 10.
Typ publikacji:: Journal Article
MeSH Terms:: Antibodies, Neutralizing/*immunology
CD8-Positive T-Lymphocytes/*immunology
Genome, Viral/*genetics
HIV Infections/*immunology
HIV-1/*genetics
gag Gene Products, Human Immunodeficiency Virus/*genetics
Cell Culture Techniques ; Enzyme-Linked Immunospot Assay ; Epitopes, T-Lymphocyte/immunology ; Genetic Fitness/genetics ; HIV Infections/virology ; HIV-1/immunology ; Humans ; Immune Evasion/genetics ; Mutation ; Selection, Genetic/genetics ; Virus Replication ; gag Gene Products, Human Immunodeficiency Virus/immunology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.
Autorzy:: Kijak GH; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Sanders-Buell E; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Chenine AL; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Eller MA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Goonetilleke N; School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Thomas R; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Leviyang S; Department of Mathematics and Statistics, Georgetown University, Washington, DC, United States of America.
Harbolick EA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Bose M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Pham P; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Oropeza C; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Poltavee K; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
O'Sullivan AM; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Billings E; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Merbah M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Costanzo MC; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Warren JA; School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Slike B; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Li H; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
Peachman KK; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Fischer W; Theoretical Biology, Los Alamos National Laboratory, Los Alamos, NM, United States of America.
Gao F; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, United States of America.
Cicala C; Laboratory of Immunoregulation National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Arthos J; Laboratory of Immunoregulation National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Eller LA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
O'Connell RJ; Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Sinei S; Walter Reed Project, Kericho, Kenya.
Maganga L; Mbeya Medical Research Programme, Mbeya, Tanzania.
Kibuuka H; Makerere University-Walter Reed Project, Kampala, Uganda.
Nitayaphan S; Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Rao M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Marovich MA; Vaccine Research Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States of America.
Krebs SJ; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Rolland M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Korber BT; Theoretical Biology, Los Alamos National Laboratory, Los Alamos, NM, United States of America.
Shaw GM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
Michael NL; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Robb ML; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Tovanabutra S; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.
Kim JH; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2017 Jul 31; Vol. 13 (7), pp. e1006510. Date of Electronic Publication: 2017 Jul 31 (Print Publication: 2017).
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections/*virology
HIV-1/*genetics
HIV-1/*isolation & purification
Adolescent ; Adult ; Cohort Studies ; Female ; HIV Infections/immunology ; HIV Infections/transmission ; HIV-1/classification ; HIV-1/physiology ; High-Throughput Nucleotide Sequencing ; Humans ; Immune Evasion ; Male ; Middle Aged ; T-Lymphocytes, Cytotoxic/immunology ; T-Lymphocytes, Cytotoxic/virology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development.
Autorzy:: Bonsignori M; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Liao HX; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Gao F; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Williams WB; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Alam SM; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Montefiori DC; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
Haynes BF; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Immunology, Duke University School of Medicine, Durham, NC, USA.; Pokaż więcej
Źródło:: Immunological reviews [Immunol Rev] 2017 Jan; Vol. 275 (1), pp. 145-160.
Typ publikacji:: Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:: AIDS Vaccines/*immunology
HIV Infections/*immunology
HIV-1/*immunology
Animals ; Antibodies, Neutralizing/metabolism ; Biological Evolution ; HIV Antibodies/metabolism ; HIV Antigens/genetics ; Host-Pathogen Interactions ; Humans ; Immune Evasion ; Mutation/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan.
Autorzy:: Chen Y; Duke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Hora B; Duke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
DeMarco T; Duke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Shah SA; Bridge Consultants Foundation, Karachi, Pakistan.
Ahmed M; Bridge Consultants Foundation, Karachi, Pakistan.
Sanchez AM; Duke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Su C; Duke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Carter M; Duke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Stone M; Blood Systems Research Institute, San Francisco, California, United States of America.
Hasan R; Department of Pathology, Aga Khan University, Karachi, Pakistan.; Department of Microbiology, Aga Khan University, Karachi, Pakistan.
Hasan Z; Department of Pathology, Aga Khan University, Karachi, Pakistan.; Department of Microbiology, Aga Khan University, Karachi, Pakistan.
Busch MP; Blood Systems Research Institute, San Francisco, California, United States of America.
Denny TN; Duke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Gao F; Duke Human Vaccine Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2016 Dec 14; Vol. 11 (12), pp. e0167839. Date of Electronic Publication: 2016 Dec 14 (Print Publication: 2016).
Typ publikacji:: Journal Article
MeSH Terms:: Recombination, Genetic*
HIV Infections/*virology
HIV-1/*genetics
Adolescent ; Adult ; Evolution, Molecular ; Female ; Genome, Viral ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Middle Aged ; Models, Statistical ; Pakistan ; Phylogeny ; Regression Analysis ; Sequence Analysis, DNA ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences.
Autorzy:: Song H; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Hora B; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Giorgi EE; Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Kumar A; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Cai F; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Bhattacharya T; Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Perelson AS; Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Gao F; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2016 Dec 02; Vol. 6, pp. 38130. Date of Electronic Publication: 2016 Dec 02.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: HIV Infections/*virology
HIV-1/*classification
HIV-1/*genetics
Genetic Variation ; Genome, Viral ; HIV Infections/transmission ; HIV-1/physiology ; Humans ; Interferon-alpha/pharmacology ; Male ; Phenotype ; Receptors, CCR5/physiology ; Receptors, HIV/physiology ; Viral Tropism/genetics ; Virus Replication/drug effects

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
Autorzy:: Rademeyer C; Division of Medical Virology & Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service (NHLS), Cape Town South Africa.
Korber B; Los Alamos National Laboratory and New Mexico Consortium, Los Alamos, New Mexico, United States of America.
Seaman MS; Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Giorgi EE; Los Alamos National Laboratory and New Mexico Consortium, Los Alamos, New Mexico, United States of America.
Thebus R; Division of Medical Virology & Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service (NHLS), Cape Town South Africa.
Robles A; Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Sheward DJ; Division of Medical Virology & Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service (NHLS), Cape Town South Africa.
Wagh K; Los Alamos National Laboratory and New Mexico Consortium, Los Alamos, New Mexico, United States of America.
Garrity J; Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Carey BR; Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
Gao H; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Greene KM; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Tang H; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Bandawe GP; Division of Medical Virology & Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service (NHLS), Cape Town South Africa.
Marais JC; Division of Medical Virology & Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service (NHLS), Cape Town South Africa.
Diphoko TE; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Hraber P; Los Alamos National Laboratory and New Mexico Consortium, Los Alamos, New Mexico, United States of America.
Tumba N; National Institute for Communicable Diseases (NICD), NHLS & University of the Witwatersrand, Johannesburg, South Africa.
Moore PL; National Institute for Communicable Diseases (NICD), NHLS & University of the Witwatersrand, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Gray GE; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg and South African Medical Research Council, Cape Town, South Africa.
Kublin J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Vermeulen M; South African National Blood Service, Weltevreden Park, South Africa.
Middelkoop K; Desmond Tutu HIV Centre, Department of Medicine and Institute of Infectious Disease and Molecular Medicine, University of Cape Town (UCT), Cape Town, South Africa.
Bekker LG; Desmond Tutu HIV Centre, Department of Medicine and Institute of Infectious Disease and Molecular Medicine, University of Cape Town (UCT), Cape Town, South Africa.
Hoelscher M; Department for Infectious Diseases & Tropical Medicine, Klinikum University of Munich, LMU and German Center for Infection Research (DZIF) partner site Munich, Munich, Germany.
Maboko L; NIMR-Mbeya Medical Research Center, Mbeya, Tanzania.
Makhema J; Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Robb ML; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Abdool Karim S; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Abdool Karim Q; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Kim JH; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; International Vaccine Institute, Seoul, Republic of Korea.
Hahn BH; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Gao F; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Swanstrom R; Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Morris L; National Institute for Communicable Diseases (NICD), NHLS & University of the Witwatersrand, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Williamson C; Division of Medical Virology & Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service (NHLS), Cape Town South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2016 Jul 19; Vol. 12 (7), pp. e1005742. Date of Electronic Publication: 2016 Jul 19 (Print Publication: 2016).
Typ publikacji:: Journal Article
MeSH Terms:: AIDS Vaccines/*immunology
HIV Infections/*immunology
HIV-1/*genetics
HIV-1/*immunology
Antibodies, Monoclonal/immunology ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Neutralizing/immunology ; Broadly Neutralizing Antibodies ; Clinical Trials as Topic ; HIV Antibodies ; HIV Envelope Protein gp120/immunology ; Humans ; Immunization, Passive/methods ; Phylogeny ; Vaccination/methods

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites.
Autorzy:: Hora B; Duke Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Keating SM; Blood Systems Research Institute, San Francisco, California, United States of America.; Department of Laboratory Medicine, University of California, San Francisco, California, United States of America.
Chen Y; Duke Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Sanchez AM; Duke Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Sabino E; Instituto de Medicina Tropical, Sao Paolo Brazil.
Hunt G; National Institute of Communicable Diseases, Johannesburg, South Africa.
Ledwaba J; National Institute of Communicable Diseases, Johannesburg, South Africa.
Hackett J Jr; Abbott Laboratories, Infectious Diseases Research, Abbott Park, Illinois, United States of America.
Swanson P; Abbott Laboratories, Infectious Diseases Research, Abbott Park, Illinois, United States of America.
Hewlett I; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Springs, Maryland, United States of America.
Ragupathy V; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Springs, Maryland, United States of America.
Vikram Vemula S; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Springs, Maryland, United States of America.
Zeng P; Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, China.
Tee KK; Centre of Excellence for Research in AIDS, Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Chow WZ; Centre of Excellence for Research in AIDS, Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Ji H; National HIV & Retrovirology Laboratories at JC Wilt Infectious Diseases Research Center, Public Health Agency of Canada, Winnipeg, Canada.
Sandstrom P; National HIV & Retrovirology Laboratories at JC Wilt Infectious Diseases Research Center, Public Health Agency of Canada, Winnipeg, Canada.
Denny TN; Duke Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Busch MP; Blood Systems Research Institute, San Francisco, California, United States of America.; Department of Laboratory Medicine, University of California, San Francisco, California, United States of America.
Gao F; Duke Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.; Pokaż więcej
Corporate Authors:: REDS-III and EQAPOL programs
Źródło:: PloS one [PLoS One] 2016 Jun 17; Vol. 11 (6), pp. e0157340. Date of Electronic Publication: 2016 Jun 17 (Print Publication: 2016).
Typ publikacji:: Journal Article
MeSH Terms:: High-Throughput Nucleotide Sequencing*
Genes, pol/*genetics
HIV Infections/*genetics
HIV-1/*genetics
Drug Resistance, Viral/genetics ; Genotype ; HIV Infections/virology ; HIV-1/drug effects ; HIV-1/pathogenicity ; Humans ; Molecular Sequence Data ; Mutation ; Phylogeny ; Recombination, Genetic

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies.
Autorzy:: Williams WB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA. .
Liao HX; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Moody MA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Kepler TB; Department of Microbiology, Boston University School of Medicine, Boston, MA, USA.
Alam SM; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Gao F; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Wiehe K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Trama AM; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Jones K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Zhang R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Song H; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Marshall DJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Whitesides JF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Sawatzki K; Department of Microbiology, Boston University School of Medicine, Boston, MA, USA.
Hua A; Department of Microbiology, Boston University School of Medicine, Boston, MA, USA.
Liu P; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Tay MZ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Seaton KE; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Shen X; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Foulger A; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Lloyd KE; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Parks R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Pollara J; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Ferrari G; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Yu JS; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Vandergrift N; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Montefiori DC; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Sobieszczyk ME; Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Hammer S; Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Gilbert P; The Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Grove D; The Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Nabel GJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Morgan C; The Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Churchyard G; The Aurum Institute, Johannesburg, South Africa.
Maenza J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Keefer M; University of Rochester School of Medicine, Rochester, NY, USA.
Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Baden LR; Brigham and Women's Hospital, Boston, MA, USA.
Tomaras GD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA. .; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2015 Aug 14; Vol. 349 (6249), pp. aab1253. Date of Electronic Publication: 2015 Jul 30.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms:: AIDS Vaccines/*immunology
HIV Antibodies/*immunology
HIV Envelope Protein gp41/*immunology
HIV-1/*immunology
Microbiota/*immunology
Vaccines, DNA/*immunology
Adenoviridae ; Antibodies, Monoclonal/genetics ; Antibodies, Monoclonal/immunology ; Antibody Formation ; Cross Reactions ; HIV Antibodies/genetics ; HIV Envelope Protein gp120/immunology ; HIV Envelope Protein gp41/genetics ; Humans ; Immunity ; Immunoglobulin Heavy Chains/genetics ; Immunoglobulin Heavy Chains/immunology ; Immunoglobulin Variable Region/genetics ; Immunoglobulin Variable Region/immunology ; Immunologic Memory ; Intestines/microbiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation.
Autorzy:: Liu D; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. .; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, 130012, Jilin, China. .
Zuo T; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. .; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, 130012, Jilin, China. .
Hora B; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. .
Song H; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. .
Kong W; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, 130012, Jilin, China. .
Yu X; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, 130012, Jilin, China. .
Goonetilleke N; Department of Microbiology, Immunology and Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. nilu_.
Bhattacharya T; Theoretical Division, Los Alamos National laboratory, Los Alamos, NM, 87545, USA. .
Perelson AS; Theoretical Division, Los Alamos National laboratory, Los Alamos, NM, 87545, USA. .
Haynes BF; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. .
McMichael AJ; Weatherall Institute of molecular Medicine, University of Oxford, Oxford, OX3 9DS, England, UK. .
Gao F; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. .; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, 130012, Jilin, China. .; Pokaż więcej
Źródło:: Retrovirology [Retrovirology] 2014 Nov 19; Vol. 11, pp. 101. Date of Electronic Publication: 2014 Nov 19.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Immune Evasion*
Mutation, Missense*
Virus Replication*
HIV-1/*immunology
HIV-1/*physiology
T-Lymphocytes/*immunology
Amino Acids/genetics ; HIV-1/genetics ; Humans ; gag Gene Products, Human Immunodeficiency Virus/genetics ; gag Gene Products, Human Immunodeficiency Virus/immunology ; gag Gene Products, Human Immunodeficiency Virus/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection.
Autorzy:: Ritchie AJ
Cai F
Smith NM
Chen S
Song H
Brackenridge S
Abdool Karim SS
Korber BT
McMichael AJ
Gao F
Goonetilleke N; Pokaż więcej
Źródło:: Retrovirology [Retrovirology] 2014 Sep 12; Vol. 11, pp. 69. Date of Electronic Publication: 2014 Sep 12.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Immune Evasion*
Recombination, Genetic*
CD8-Positive T-Lymphocytes/*immunology
HIV Infections/*immunology
HIV-1/*genetics
Acute Disease ; Adult ; HIV-1/physiology ; Humans ; Male ; Virus Replication

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Extensive recombination due to heteroduplexes generates large amounts of artificial gene fragments during PCR.
Autorzy:: Liu J; Department of Microbiology, Peking University Health Science Center, Beijing, China.
Song H; Department of Medicine, Duke University Medical Center, Durham, North Carolina, United State of America.
Liu D; Department of Medicine, Duke University Medical Center, Durham, North Carolina, United State of America; National Engineering Laboratory for AIDS Vaccine, College of Life Science, Jilin University, Changchun, Jilin, China.
Zuo T; Department of Medicine, Duke University Medical Center, Durham, North Carolina, United State of America; National Engineering Laboratory for AIDS Vaccine, College of Life Science, Jilin University, Changchun, Jilin, China.
Lu F; Department of Microbiology, Peking University Health Science Center, Beijing, China.
Zhuang H; Department of Microbiology, Peking University Health Science Center, Beijing, China.
Gao F; Department of Medicine, Duke University Medical Center, Durham, North Carolina, United State of America; National Engineering Laboratory for AIDS Vaccine, College of Life Science, Jilin University, Changchun, Jilin, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Sep 11; Vol. 9 (9), pp. e106658. Date of Electronic Publication: 2014 Sep 11 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Recombination, Genetic*
DNA/*genetics
HIV-1/*genetics
Polymerase Chain Reaction/*methods
Genetic Variation ; High-Throughput Nucleotide Sequencing ; Humans ; Nucleic Acid Heteroduplexes/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus.
Autorzy:: Song H; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Hora B; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Bhattacharya T; Theoretical Division, Los Alamos National laboratory, Los Alamos, New Mexico, United States of America; Santa Fe Institute, Santa Fe, New Mexico, United States of America.
Goonetilleke N; Weatherall Institute of molecular Medicine, University of Oxford, Oxford, England, United Kingdom.
Liu MK; Weatherall Institute of molecular Medicine, University of Oxford, Oxford, England, United Kingdom.
Wiehe K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Li H; Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Iyer SS; Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
McMichael AJ; Weatherall Institute of molecular Medicine, University of Oxford, Oxford, England, United Kingdom.
Perelson AS; Theoretical Division, Los Alamos National laboratory, Los Alamos, New Mexico, United States of America.
Gao F; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Jul 16; Vol. 9 (7), pp. e102734. Date of Electronic Publication: 2014 Jul 16 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: CD8-Positive T-Lymphocytes/*immunology
Genetic Fitness/*genetics
Genome, Viral/*genetics
HIV-1/*genetics
Immune Evasion/*genetics
Mutation, Missense/*genetics
Base Sequence ; CD8-Positive T-Lymphocytes/virology ; DNA Primers/genetics ; Enzyme-Linked Immunospot Assay ; Humans ; Molecular Sequence Data ; Sequence Analysis, DNA ; Virus Replication/genetics ; Virus Replication/physiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: The variable loop 3 in the envelope glycoprotein is critical for the atypical coreceptor usage of an HIV-1 strain.
Autorzy:: Xiang Y; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, Jilin, China.
Liu W; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, Jilin, China.
Chen Y; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Zhang C; The 2nd Division of In Vitro Diagnostic, National Institutes for Food and Drug Control, Beijing, China.
Su W; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, Jilin, China.
Zhang Y; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, Jilin, China.
Sun J; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, Jilin, China.
Gao F; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, Jilin, China; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Jiang C; National Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, Jilin, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Jun 04; Vol. 9 (6), pp. e98058. Date of Electronic Publication: 2014 Jun 04 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: HIV Envelope Protein gp120/*metabolism
HIV-1/*metabolism
Receptors, G-Protein-Coupled/*metabolism
Receptors, Peptide/*metabolism
CD4-Positive T-Lymphocytes/metabolism ; Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
Autorzy:: Fenton-May AE; Nuffield Department of Medicine, University of Oxford, NDM Research Building, Old Road Campus, Headington, Oxford OX3 7FZ, UK. .
Dibben O
Emmerich T
Ding H
Pfafferott K
Aasa-Chapman MM
Pellegrino P
Williams I
Cohen MS
Gao F
Shaw GM
Hahn BH
Ochsenbauer C
Kappes JC
Borrow P; Pokaż więcej
Źródło:: Retrovirology [Retrovirology] 2013 Dec 03; Vol. 10, pp. 146. Date of Electronic Publication: 2013 Dec 03.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Drug Resistance, Viral*
HIV Infections/*virology
HIV-1/*drug effects
HIV-1/*immunology
Interferon-alpha/*immunology
Interferon-alpha/*pharmacology
Virus Replication/*drug effects
HIV Infections/immunology ; HIV-1/isolation & purification ; Humans ; Inhibitory Concentration 50 ; Microbial Sensitivity Tests

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Gao, F."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język